Biocept, Inc.

BIOC · NASDAQ
Analyze with AI
6/30/2023
3/31/2023
12/31/2022
9/30/2022
Operating Activities
Net Income-$4-$7-$19-$6
Dep. & Amort.$0$1$0$0
Deferred Tax$0-$0$0$0
Stock-Based Comp.$0$0$0$0
Change in WC$2$0$14$0
Other Non-Cash-$2$0$0$0
Operating Cash Flow-$3-$6-$4-$4
Investing Activities
PP&E Inv.-$0-$0-$0-$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow-$0-$0-$0-$0
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$4$0$0$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$3$0-$1-$0
Financing Cash Flow$3$0-$1-$0
Forex Effect$0$0$0$0
Net Chg. in Cash-$0-$6-$5-$5
Supplemental Information
Beg. Cash$7$13$18$23
End Cash$7$7$13$18
Free Cash Flow-$3-$6-$4-$4
Biocept, Inc. (BIOC) Financial Statements & Key Stats | AlphaPilot